(571) 447-5500

EAS Blog

EAS Independent Consultants and staff provide in-depth regulatory expertise and authoritative reporting on a variety of compliance requirements for industries that EAS serves. Our experts break down complicated topics into easily understandable summaries and analysis. Subscribe to our newsletter and receive these monthly updates directly in your in-box.

Investigating Pesticide Tolerance

Investigating Pesticide Tolerance

By Dr. Bill Reeves, EAS Regulatory ConsultantConsistent, scientifically justified regulations enable over $1.5 trillion in global agricultural exports every year. The world economy depends on these regulations to ensure whatever goes onto a ship is legal to sell when it reaches port. One key...

read more
Drug and Device September 2024

Drug and Device September 2024

The FDA Drug and Medical Device Registration renewal period begins 1 October 2024. With the drug listing certification period upon us, it is a good time to confirm your NDC listings are all accurate.  Any NDC SPL file requiring updates should be done prior to 31 December 2024.  The marketing...

read more
FY2025 Drug Program User Fees

FY2025 Drug Program User Fees

Please see below information regarding FY2025 Drug Program User Fees which go into effect 1 October 2024. The FDA has announced FY2025 user fees for GDUFA, OMUFA (Order Requests only), PDUFA, BsUFA, and animal user fee programs. Please see the Federal Register notices for details on each. FR Vol....

read more
Claims Substantiation of Cosmetic Products

Claims Substantiation of Cosmetic Products

An EAS Consulting Group Complimentary On Demand WebinarPresented by Paula Brock, Ph.D., MCSISeptember 9, 2024 • 11:30 AM (Eastern) • Length: 45 minutesSubstantiation of product claims is required by law in the USA and this is not different for cosmetics. All types of claims need to be...

read more
FY2025 Medical Device Fees

FY2025 Medical Device Fees

Please see below information regarding FY2025 Medical Device User Fees which go into effect 1 October 2024. Keep in mind, the FY2025 facility user fee must be paid prior to processing your annual renewal during the renewal period Oct 1 – Dec 31. FY2025 Medical Device facility registration user...

read more
AHPA Claims Substantiation Tools and Trends

AHPA Claims Substantiation Tools and Trends

AHPA Claims Substantiation Tools and TrendsPresented by Paula Brock, Ph.D., MCSIThis is a portion of a webinar produced by the American Herbal Products Association (AHPA) originally held July 9, 2024.Enter Your Information to Watch NowBy clicking submit above, you consent to allow EAS Consulting...

read more
Drug and Device August 2024

Drug and Device August 2024

FDA issued a proposed administrative order to amend the requirements for internal analgesic, antipyretic, and antirheumatic drug products for OTC human use, as currently described in OTC Monograph M013. The proposed change will require the addition of a warning to the labeling of OTC internal...

read more
How to Build an Achieving Team

How to Build an Achieving Team

By Eiman Raouf, EAS Senior Regulatory ConsultantUpon entering various organizations, scenarios often unfold where operational efficiency falls short. Quality lapses in production, a surge in customer grievances, or perpetual crisis management seem to be the norm rather than the exception....

read more
Drug and Device July 2024

Drug and Device July 2024

FDA has sent notices to drug establishment registrants reminding OTC hand sanitizer manufacturers who entered the market solely to provide hand sanitizer during the COVID-19 public health emergency, that beginning FY2025 OMUFA facility user fees will become mandatory. The FDA had previously...

read more
FDA Enhances Tobacco Retailer Inspection Database

FDA Enhances Tobacco Retailer Inspection Database

This week, FDA’s Center for Tobacco Products updated the presentation of information about tobacco compliance check outcomes on the FDA website and expanded the information available. The newly-named Tobacco Compliance Check Outcomes database provides an enhanced user experience by housing results...

read more
Import Refusals – “Don’t Panic”

Import Refusals – “Don’t Panic”

By Mark Moen, EAS Consulting Group Senior Regulatory ConsultantProducts imported into the US may be assessed and inspected by US Customs and Border Protection (CBP), the Food and Drug Administration (FDA), and US Consumer Products Safety Commission (CPSC). US Customs and Border Protection (CBP) is...

read more
Drug and Device June 2024

Drug and Device June 2024

Final reminder that CARES Act drug amount reports for 2023 are due by 31 July 2024. If you need assistance with this process, reach out to Victoria Pankovich for support.The FDA announced the availability of a final guidance for industry titled “Facility Readiness: Goal Date Decisions Under...

read more
FDA Releases Update of Priority Guidance Topics for Foods Program

FDA Releases Update of Priority Guidance Topics for Foods Program

Earlier this year, the FDA released the draft and final guidance topics that are a priority for the agency’s Foods Program to complete during 2024. Since January, the FDA has issued the following guidances that were on the list: New Dietary Ingredient (NDI) Notifications and Related Issues: NDI...

read more
Product Claim Substantiation

Product Claim Substantiation

By Jay Ansell, EAS Independent ConsultantSubstantiating a product claim is required by U.S. law and can help brands avoid regulatory action or provide an effective defense in litigation. For example, in April 2023, the US Federal Trade Commission (FTC), responsible for enforcing federal laws...

read more
Drug and Device May 2024

Drug and Device May 2024

Final reminder that OMUFA facility user fees are due 1 June 2024. Per MoCRA, responsible persons are required to submit any serious adverse event reports to the FDA within 15 business days of receiving such report. Cosmetic labels are required to include a domestic address, domestic phone number,...

read more
Quality Management System (QMS) Documentation

Quality Management System (QMS) Documentation

By Jeff VanderHoek, EAS Independent ConsultantThe design and manufacturing of medical devices requires a high level of quality and reliability to ensure patient safety and regulatory compliance. The Quality Management System (QMS) that a company creates and puts in place plays a key role in...

read more
Drug and Device April 2024

Drug and Device April 2024

FDA announced the fiscal year 2024 OTC-Monograph Drug User Fee rates in the Federal Register Vol 89, No. 62 published 29 March 2024. These fees cover FDA’s FY2024 which runs from October 2023 through September 2024.  The facility fees for FY 2024 are due on 3 June 2024. Regarding fee specifics,...

read more
US label and EU label: food labeling in comparison

US label and EU label: food labeling in comparison

Gisela Leon, EAS Consulting Group Independent ConsultantInterviewed for Industrie- und Handelskammer HannoverApril 4, 2024Published in GermanWithin the European Union, food labeling is clearly regulated. In the USA, too, it is - but different. The Food and Drug Administration (FDA) and the United...

read more
Control of Cronobacter in Dairy Dryer and Packaging Rooms

Control of Cronobacter in Dairy Dryer and Packaging Rooms

By Beth Koenig, EAS Independent ConsultantWhat Is Cronobacter and Why Should We Be Concerned About It? Cronobacter, a genus of bacterial pathogens in the Enterobacteriacea family is of considerable concern in infant formula manufacturing and in the manufacture of products for populations with...

read more
FY2024 OMUFA User Fees Announced by FDA

FY2024 OMUFA User Fees Announced by FDA

FDA announced the fiscal year 2024 OTC-Monograph Drug User Fee rates in the Federal Register Vol 89, No. 62 published 29 March 2024. These fees cover FDA’s FY2024 which runs from October 2023 through September 2024. The facility fees for FY 2024 are due on 3 June 2024. Regarding fee specifics,...

read more